
News|Articles|May 1, 2005
First-time generic approvals
Anti-sense compound (LR3001, Genta) for the treatment of chronic myelocytic leukemia
Advertisement
Dantrolene capsules 25, 50, and 100 mg (equiv to Dantrium capsules)
IMPAX
Griseofulvin oral suspension 125 mg/5 mL (equiv to Grifuvin V)
STIEFEL
Octreotide injection (preservative free) 0.05, 0.1, and 0.5 mg/mL (equiv to Sandostatin)
BEDFORD
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Could GLP-1s help with cognitive symptoms, pychosis of schizophrenia?
4
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
5























